Cowen And Company, LLC Gilead Sciences, Inc. Call Options Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $577,200 - $650,100	-10,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $579,200 - $725,800	10,000 New	10,000 $1,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $1.01 Million - $1.18 Million	-14,000 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $876,820 - $1.12 Million	14,000 New	14,000 $98,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.